scholarly journals A bioprosthetic total artificial heart for end-stage heart failure: Results from a pilot study

2018 ◽  
Vol 37 (1) ◽  
pp. 33-37 ◽  
Author(s):  
Christian Latrémouille ◽  
Alain Carpentier ◽  
Pascal Leprince ◽  
Jean-Christian Roussel ◽  
Bernard Cholley ◽  
...  
2019 ◽  
Vol 21 (1) ◽  
pp. 85-110 ◽  
Author(s):  
Eleonora Dal Sasso ◽  
Andrea Bagno ◽  
Silvia T.G. Scuri ◽  
Gino Gerosa ◽  
Laura Iop

There are limited therapeutic options for final treatment of end-stage heart failure. Among them, implantation of a total artificial heart (TAH) is an acceptable strategy when suitable donors are not available. TAH development began in the 1930s, followed by a dramatic evolution of the actuation mechanisms operating the mechanical pumps. Nevertheless, the performance of TAHs has not yet been optimized, mainly because of the low biocompatibility of the blood-contacting surfaces. Low hemocompatibility, calcification, and sensitivity to infections seriously affect the success of TAHs. These unsolved issues have led to the withdrawal of many prototypes during preclinical phases of testing. This review offers a comprehensive analysis of the pathophysiological events that may occur in the materials that compose TAHs developed to date. In addition, this review illustrates bioengineering strategies to prevent these events and describes the most significant steps toward the achievement of a fully biocompatible TAH.


1989 ◽  
Vol 35 (3) ◽  
pp. 229-230 ◽  
Author(s):  
KEVIN D. MURRAY ◽  
P. DAVID MYEROWITZ ◽  
KIM M. WATSON ◽  
PATTY A. LOWE ◽  
LAURI K. KALANGES ◽  
...  

1989 ◽  
Vol 35 (3) ◽  
pp. 229-230
Author(s):  
KEVIN D. MURRAY ◽  
P. DAVID MYEROWITZ ◽  
KIM M. WATSON ◽  
PATTY A. LOWE ◽  
LAURI K. KALANGES ◽  
...  

2013 ◽  
Vol 62 (18) ◽  
pp. C45
Author(s):  
Serkan Ertugay ◽  
Özlem Balcıoğlu ◽  
Ayşen Yaprak Engin ◽  
Emrah Oğuz ◽  
Çağatay Engin ◽  
...  

2019 ◽  
Vol 64 (3) ◽  
pp. 247-250
Author(s):  
Sotirios Spiliopoulos ◽  
Vera Hergesell ◽  
Andrae Wasler ◽  
Otto Dapunt

AbstractDue to the declining instances of organ donation, total artificial heart (TAH) therapy is of increasing importance for the management of end-stage biventricular heart failure. We introduce the currently most important established and novel TAH systems (SynCardia, CARMAT, ReinHeart, BiVACOR), report clinical outcomes and discuss technical requirements for the successful implementation of TAH therapy as an alternative to cardiac transplantation.


2014 ◽  
Vol 46 (6) ◽  
pp. 935-936 ◽  
Author(s):  
R. Koerfer ◽  
S. Spiliopoulos ◽  
T. Finocchiaro ◽  
D. Guersoy ◽  
G. Tenderich ◽  
...  

1999 ◽  
Vol 69 (7) ◽  
pp. 305-309
Author(s):  
M. HACHIDA ◽  
昌也 北村 ◽  
明彦 川合 ◽  
博 西田 ◽  
真弘 遠藤 ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document